These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4964957)

  • 1. [New experience with cytostatics, especially their intra-arterial use in bladder tumors].
    Reuter JH
    Z Urol Nephrol; 1966 Feb; 59(2):125-8. PubMed ID: 4964957
    [No Abstract]   [Full Text] [Related]  

  • 2. [Local chemotherapy of bladder epitheliomas].
    Martinez-Piñeiro JA
    Acta Oncol (Madr); 1970; 9(1):1-27. PubMed ID: 4990619
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and experimental projects on chemotherapy of bladder tumours.
    Pavone-Macaluso M; Rausa L; Gebbia N; Caramia G; Rizzo FP; Arena E; Tessitore V; Vecchioni M
    S Afr Med J; 1974 Mar; 48(15):631-6. PubMed ID: 4378338
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy in the management of bladder tumours.
    Gibson GR
    Aust N Z J Surg; 1969 Feb; 38(3):281-3. PubMed ID: 4975184
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravesical chemotherapy in the management of superficial bladder tumors.
    Schulman CC
    Prog Clin Biol Res; 1984; 153():275-85. PubMed ID: 6433356
    [No Abstract]   [Full Text] [Related]  

  • 6. [Low-grade, low-stage transitional carcinoma of the bladder. Analysis of 147 cases].
    Escudero Barrilero A; Gutiérrez Sanz-Gadea C; Hernández Fernández C; Mateos Torres A; Maganto Pavón E; Mayayo Dehesa T
    Actas Urol Esp; 1985; 9(2):135-46. PubMed ID: 3925729
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adrianycin as intracavitary coadjuvant treatment of superficial bladder tumors. Our initial experiences].
    Martínez Lasierra M; Caro Cebrián C; Sanz Vélez JI; Roncalés A; Rioja Sanz C
    Actas Urol Esp; 1981; 5(4):219-22. PubMed ID: 6797270
    [No Abstract]   [Full Text] [Related]  

  • 8. [Regional intra-arterial chemotherapy in tumors of the urinary bladder].
    Taukenov MT; Minakova LR
    Urol Nefrol (Mosk); 1967; 32(5):76-80. PubMed ID: 4983861
    [No Abstract]   [Full Text] [Related]  

  • 9. Rationale for intensive intravesical chemotherapy.
    Soloway MS
    Prog Clin Biol Res; 1984; 153():287-95. PubMed ID: 6433357
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progress in the internist treatment of bladder tumors].
    Baumgartner G
    Wien Med Wochenschr; 1982 Jul; 132(13-14):305-12. PubMed ID: 6814073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of intravesical thiotepa in the management of superficial bladder cancer. National Bladder Cancer Collaborative Group A.
    Cancer Res; 1977 Aug; 37(8 Pt 2):2916-7. PubMed ID: 406040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors.
    Veenema RJ; Dean AL; Uson AC; Roberts M; Longo F
    J Urol; 1969 May; 101(5):711-5. PubMed ID: 4976352
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy in superficial neoplasms of the bladder.
    Zingg E; Sulmoni A
    S Afr Med J; 1972 Jul; 46(27):916-7. PubMed ID: 4626807
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemoprophylaxis of bladder cancer recurrence: immunological aspects.
    Corrado F; Lalanne G; Pizza GC
    Panminerva Med; 1974 Mar; 16(3):85-91. PubMed ID: 4217438
    [No Abstract]   [Full Text] [Related]  

  • 15. [Local chemotherapy of papillary neoplasms of the bladder].
    Pavone-Macaluso M
    Pol Tyg Lek; 1973 Apr; 28(14):523-30. PubMed ID: 4633501
    [No Abstract]   [Full Text] [Related]  

  • 16. Is immediate postoperative intravesical chemotherapy beneficial in non-muscle- invasive bladder cancer?
    Ayres BE; Crew JP;
    BJU Int; 2010 Feb; 105 Suppl 2():14-7. PubMed ID: 20089093
    [No Abstract]   [Full Text] [Related]  

  • 17. New approaches to intravesical chemo-immunotherapy in superficial bladder cancer.
    van der Meijden AP
    Prog Clin Biol Res; 1992; 378():95-101. PubMed ID: 1301591
    [No Abstract]   [Full Text] [Related]  

  • 18. Only an overall 15% net benefit emerges in favour of adjuvant intravesical chemotherapy when compared to transurethral resection alone for the prevention of recurrences of superficial bladder tumors.
    Colombo R
    Eur Urol; 2006 Aug; 50(2):233-4. PubMed ID: 18219715
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preventive value of intravesical thiotepa on the recurrence of Ta-T1 vesical tumors treated by conservative surgery. Apropos of 247 cases a mean follow-up of 88 months].
    Gilloz A; Sauvage I; Gremillet E; Héritier P; Richard A; el Hajj E; Diez-Yanguas J
    J Urol (Paris); 1987; 93(4):197-202. PubMed ID: 3119728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of bladder cancer: a review.
    Smith PH
    Cancer Treat Rep; 1981; 65 Suppl 1():165-73. PubMed ID: 6799197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.